Landmark Gene-Editing Study Advances After China Crispr Clamor

(Bloomberg) -- After a global controversy over a Chinese scientist’s surprise claims that he’d edited the DNA of human embryos, U.S. regulators blessed a small company’s quest to use the same genet...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.